YAMHY yields 11.76% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, YAMHY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YAMHY + PFE for your $10,000?
Yamaha Motor Co., Ltd., together with its subsidiaries, engages in the land mobility, marine products, robotics, and financial services businesses in Japan, North America, Europe, Asia, and internationally. Its Land Mobility segment offers motorcycles, leaning multi-wheelers, all-terrain vehicles, recreational off highway vehicles, snowmobiles, electrically power-assisted bicycles, electric wheelchairs, automobile engines, and automobile components, as well as intermediate parts for products, and knockdown parts. The company's Marine Products segment provides outboard motors, personal watercraft, boats, FRP pools, fishing boats, and utility boats. Its Robotics segment offers surface mounters, semiconductor manufacturing equipment, industrial robots, and industrial-use unmanned helicopters. The company's Financial Services segment provides sales finance and lease related to the company's products. Its Others segment offers golf cars, generators, multi-purpose engines, and snow blowers. Yamaha Motor Co., Ltd. was incorporated in 1918 and is headquartered in Iwata, Japan.
Full YAMHY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.